Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 2,6 Diisopropylanilinide Lithium. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108503659A reveals efficient lithium catalyst for ketone hydroboration. Reduces cost and time for pharmaceutical intermediate manufacturing significantly.
Efficient hydroboration using 2,6-diisopropylanilinide lithium for pharmaceutical intermediates. Reduces cost and improves supply chain reliability significantly.